GAS6, major ligand of AXL receptor tyrosine kinase, is also notable because it has been demonstrated to be overexpressed and activated in many human cancers such as lung, breast, and pancreatic, and have been correlated with poor prognosis, promotion of increased invasiveness and metastasis, the EMT phenotype and drug resistance [47–51]. Here, AXL is linked to cancer.